Brief: Cullinan Oncology Forms Strategic Collaboration Agreement With Mount Sinai To Advance Oral HPK1 Protein Degrader For Cancer Treatment
10/01/2022 11:35
Jan 10 (Reuters) - Cullinan Oncology Inc CGEM.O :
* CULLINAN ONCOLOGY FORMS STRATEGIC COLLABORATION AGREEMENT WITH MOUNT SINAI
TO
ADVANCE ORAL HPK1 PROTEIN DEGRADER FOR CANCER TREATMENT
* CULLINAN ONCOLOGY INC - EXCLUSIVE OPTION FOR CULLINAN TO LICENSE RELATED
INTELLECTUAL PROPERTY FROM COLLABORATION
* CULLINAN ONCOLOGY INC - COLLABORATION TO IDENTIFY AND ADVANCE
BEST-IN-CLASS HPK1
PROTEIN DEGRADERS
Source text for Eikon: ID:nGNX863cPY
Further company coverage: CGEM.O